MISSISSAUGA, ON, Oct. 3, 2014 /CNW/ – MyndTec, an award-winning, Canadian medical technology company announced today the launch of its first commercial product, a revolutionary, new therapy for the treatment of arm and hand paralysis caused by stroke or spinal cord injury. MyndMove™ therapy is based on advanced non-invasive functional electrical stimulation and uses electrical stimulation to create new neural pathways for the recovery of voluntary function following injury to the brain or spinal cord.
Over the coming week, MyndTec will unveil MyndMove at two rehabilitation conferences in Toronto, the National Spinal Cord Injury Conference (Oct 3–4) and the American Congress of Rehabilitation Medicine (Oct 8-10).
“This is truly a landmark moment in the evolution of FES therapy,” said MyndTec Founder Dr. Milos R. Popovic. “Multiple clinical studies have demonstrated the safety and efficacy of FES therapy for the treatment of paralysis and we can now offer this life-changing therapy to patients that might benefit”.
“What makes MyndMove therapy so exciting is that the recovery of arm and hand function means that patients become more independent in performing routine activities of daily living such as eating, grooming, dressing and bathing,” said Diana Pliura, CEO of MyndTec. “With increased independence, patients gain dignity and the burden on families and our healthcare system is decreased.”
Today’s launch marks MyndTec’s entrance into the neurorehabilitation market and MyndMove therapy will initially be available at designated physiotherapy clinics across Ontario.
MyndTec Inc. (formerly Simple Systems Inc.) is a privately held medical technology company located in Mississauga, Ontario, that develops and commercializes innovative medical devices designed to improve function, maximize independence and enhance quality of life. MyndTec was founded in 2008 as Simple Systems Inc., to the commercialize technology developed by Dr. Milos Popovic and his colleagues at the Toronto Rehabilitation Institute and the Institute of Biomaterials and Biomedical Engineering and the University of Toronto. For more information on MyndTec and MyndMove™ and authorized indications, please visit http://www.myndtec.com.
SOURCE MyndTec Inc.